Additional File 4: of SMAD4 and NF1 Mutations As Potential Biomarkers for Poor Prognosis to Cetuximab-Based Therapy in Chinese Metastatic Colorectal Cancer Patients

Mingqing Zhu,Yang Shao,Peinan Lin,Xiaoxiao Cai,Biao Wang,Yan Ding,Xiongfeng Ma,Xue Wu,Yewei Xia,Dongqin Zhu,Yongqian Shu,Zan Fu,Yanhong Gu

DOI: https://doi.org/10.6084/m9.figshare.6197369

2018-01-01

Abstract:Table S3. Statistical difference of PFS of patients with or without mutations in a specific gene. (XLSX 10 kb)